Experimental Hematology & Oncology

Experimental Hematology & Oncology accepted for inclusion in SCIE

New Content Item We are delighted to announce that Experimental Hematology & Oncology has been accepted for inclusion in Science Citation Index Expanded (SCIE), a key database of Web of Science, published by Clarivate Analytics. Starting 2020, Experimental Hematology & Oncology will be published in the annual Journal Citation Reports, at which point it will receive the associated journal metrics, such as Immediacy Index, Eigenfactor Score, and Journal Impact Factor.

Aims and scope

Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.

Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia

Authors: Jifeng Yu, Yingmei Li, Tao Li, Yafei Li, Haizhou Xing, Hui Sun, Ling Sun, Dingming Wan, Yanfang Liu, Xinsheng Xie and Zhongxing Jiang

Content type: Research

6 January 2020
The SMAC mimetic LCL-161 selectively targets JAK2^V617F mutant cells

Authors: Brianna M. Craver, Thanh Kim Nguyen, Jenny Nguyen, Hellen Nguyen, Christy Huynh, Sarah J. Morse and Angela G. Fleischman

Content type: Research

2 January 2020
Immune pressures drive the promoter hypermethylation of neoantigen genes

Authors: Ming Yi, Bing Dong, Qian Chu and Kongming Wu

Content type: Editorial

29 November 2019

The Article to this article has been published in Nature 2019 567:1032
Gut microbiome and CAR-T therapy

Authors: Muhammad Bilal Abid, Nirav N. Shah, Theresa C. Maatman and Parameswaran N. Hari

Content type: Review

19 November 2019
A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma

Authors: Shanshan Zhang, Zhaojian Gong, Peter O. Oladimeji, Duane G. Currier, Qipan Deng, Ming Liu, Taosheng Chen and Yong Li

Content type: Research

15 November 2019

Most recent articles RSS

View all articles

Breast cancer brain metastases: the last frontier

Authors: José Pablo Leone and Bernardo Amadeo Leone

Content type: Review

24 November 2015
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy

Authors: Kemeng Wang, Guoqing Wei and Delong Liu

Content type: Review

29 November 2012
Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies

Authors: Theresa L Schwartz, Harveshp Mogal, Christos Papageorgiou, Jula Veerapong and Eddy C Hsueh

Content type: Review

14 November 2013
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis

Authors: Shamudheen M Rafiyath, Mohammad Rasul, Byung Lee, Guoqing Wei, Gurpreet Lamba and Delong Liu

Content type: Research

23 April 2012
The development of bispecific antibodies and their applications in tumor immune escape

Authors: Xiaolong Zhang, Yuanyuan Yang, Dongmei Fan and Dongsheng Xiong

Content type: Review

2 May 2017

Most accessed articles RSS

View all articles

Editors-in-Chief

Kongming Wu, Tongji Medical College
Delong Liu, New York Medical College
Zihai Li, Medical University of South Carolina

Editor's quote (Dr. Delong Liu)

"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. It also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."

Latest Tweets

Experimental Hematology & Oncology